Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects

Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects

Background & objectives: The persistence of the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 pandemic, partly due to the appearance of highly infectious variants, has made booster vaccinations necessary for vulnerable groups. Here, we present data regarding the decline of the SARS-...

Full description

Bibliographic Details
Main Authors: Alfieri, G. (Author), Amato, G. (Author), Andreone, V. (Author), De Rosa, V. (Author), Della Rocca, G. (Author), Di Battista, M.E (Author), Di Giulio Cesare, D. (Author), Di Iorio, W. (Author), Ferrara, A.L (Author), Graziano, D. (Author), Liotti, A. (Author), Maniscalco, G.T (Author), Manzo, V. (Author), Moreggia, O. (Author), Salvatore, S. (Author), Viola, A. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
BNT162b2-mRNA vaccine
Coronavirus-19
Disease modifying therapies
Humoral persistence
Multiple sclerosis
SARS-CoV-2 spike protein
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items